Rocket Pharmaceuticals Inc (RCKT)
EBITDA Growth
102.37%
TTM · Period ending:
RCKT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported102.37%period ending
Latest reported102.37%period ending
RCKT TTM EBITDA YoY % (-56.82% → 102.37%)
Year-over-year change
High-resolution chart · PNG
RCKT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 102.3685% | |
| 20.9553% | |
| 16.2087% | |
| 7.8444% | |
| -0.8364% | |
| -2.616% | |
| -4.5909% | |
| -0.9476% | |
| -0.9507% | |
| -4.5864% | |
| -10.7325% | |
| -30.3304% | |
| -33.432% | |
| -42.1133% | |
| -35.4101% | |
| -6.5461% | |
| -16.4568% | |
| -11.1639% | |
| -20.5138% | |
| -93.3345% | |
| -88.1474% | |
| -89.2015% | |
| -83.0772% | |
| -16.1912% | |
| -8.8793% | |
| -5.6157% | |
| -3.9079% | |
| -66.6872% | |
| -94.0356% | |
| -160.0279% | |
| -315.7205% | |
| -91.0024% | |
| -36.7131% | |
| 17.9028% | |
| 60.1051% | |
| 34.6096% | |
| 12.5046% | |
| -32.7234% | |
| -123.8378% | |
| -213.7687% | |
| -275.9142% | |
| -183.4863% | |
| -140.6802% | |
| -56.8167% |